Literature DB >> 22476599

Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.

Catherine S Nation1, Blaise Dondji, Gabrielle A Stryker.   

Abstract

The geographic distribution of Leishmania major overlaps with several other species of Leishmania. This study seeks to examine what effect previous exposure to L. major has on the outcome of infection with Leishmania infantum, the agent of virulent visceral leishmaniasis. The L. major immune response is well characterized by a strong Th1 response leading to resolution and protection against subsequent re-infection. A contrasting Th2 immune response leads to disseminated disease, while the role Th17 cytokines may play in Leishmania infection is still being explored. The cytokine profile, antibody titer, and parasite burden were evaluated in the susceptible BALB/c mouse after L. infantum infection in either naïve mice or those previously infected with a low/self-healing dose of L. major. Only IL-4 expression in mice previously exposed to L. major was found to be significantly increased over controls, a cytokine with an ambiguous role in L. infantum infection. However, disease exacerbation, with a notably higher parasite burden, was observed in the L. major exposed mice compared to the L. infantum only. Cross-reactive antibodies were seen in both groups of infected mice regardless of their immune history. Studies have shown a role for opsonizing antibodies leading to increased disease in visceral leishmaniasis. We speculate that cross-reactive antibodies may be playing a role in augmenting visceral disease in mice with immunological memory to L. major.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476599     DOI: 10.1007/s00436-012-2899-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  61 in total

Review 1.  Immunologic memory in cutaneous leishmaniasis.

Authors:  Phillip Scott
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

2.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

3.  Expression cloning of a protective Leishmania antigen.

Authors:  E Mougneau; F Altare; A E Wakil; S Zheng; T Coppola; Z E Wang; R Waldmann; R M Locksley; N Glaichenhaus
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

4.  Vaccination of BALB/c mice with Leishmania donovani derived lipophosphoglycan does not conver cross-protection to L. major infections.

Authors:  W K Tonui
Journal:  East Afr Med J       Date:  2003-05

Review 5.  Tissue granuloma structure-function in experimental visceral leishmaniasis.

Authors:  H W Murray
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

6.  Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major.

Authors:  R Killick-Kendrick; A D Bryceson; W Peters; D A Evans; A J Leaney; J A Rioux
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

7.  Epidemiology of visceral leishmaniasis in northeast Brazil.

Authors:  T G Evans; M J Teixeira; I T McAuliffe; I Vasconcelos; A W Vasconcelos; A de A Sousa; J W Lima; R D Pearson
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: perspectives on the age and origins of parasitism.

Authors:  A P Fernandes; K Nelson; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.

Authors:  Suzanne A Miles; Sean M Conrad; Renata G Alves; Selma M B Jeronimo; David M Mosser
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  3 in total

1.  Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.

Authors:  Audrey Romano; Nicole A Doria; Jonatan Mendez; David L Sacks; Nathan C Peters
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

2.  Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.

Authors:  José Carlos Solana; Laura Ramírez; Laura Corvo; Camila Indiani de Oliveira; Manoel Barral-Netto; José María Requena; Salvador Iborra; Manuel Soto
Journal:  PLoS Negl Trop Dis       Date:  2017-05-30

Review 3.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.